G MEDPAR |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.02 USD | +17.65% |
|
+5.82% | -7.41% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 21.5 | 22.49 | 3.283 | 5.288 |
| Enterprise Value (EV) 1 | 21.5 | 24.29 | 3.283 | 5.288 |
| P/E ratio | -0.27 x | - | -0.1 x | - |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | 4.45 x | - | 0.26 x |
| EV / Revenue | - | 4.45 x | - | 0.26 x |
| EV / EBITDA | - | -2,269,717 x | - | - |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 267 | 385 | 1,001 | 264,417 |
| Reference price 2 | 80.50 | 58.45 | 3.280 | 0.0200 |
| Announcement Date | 4/22/21 | 4/29/22 | 5/16/23 | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net sales 1 | - | 5.058 | - | 20.4 |
| EBITDA | - | -9.907 | - | - |
| EBIT | - | -11.27 | - | - |
| Operating Margin | - | -222.8% | - | - |
| Earnings before Tax (EBT) 1 | - | - | - | -3.6 |
| Net income 1 | -12.69 | - | -13.52 | -3.6 |
| Net margin | - | - | - | -17.65% |
| EPS | -297.5 | - | -34.17 | - |
| Free Cash Flow | - | - | - | - |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 4/22/21 | 4/29/22 | 5/16/23 | - |
1USD in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 S1 |
|---|---|
| Net sales | - |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income 1 | -4.694 |
| Net margin | - |
| EPS 2 | -17.85 |
| Dividend per Share | - |
| Announcement Date | 9/15/21 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net Debt | - | 1.81 | - | - |
| Net Cash position | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -0.1825 x | - | - |
| Free Cash Flow | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share | - | - | - | - |
| Cash Flow per Share | - | - | - | - |
| Capex | - | - | - | - |
| Capex / Sales | - | - | - | - |
| Announcement Date | 4/22/21 | 4/29/22 | 5/16/23 | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.02
USD
Average target price
210
USD
Spread / Average Target
+1,049,901.05%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GMVDF Stock
- Financials G MEDPAR
